Sponsor Pipeline

Suzhou Forlong Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07122414 A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive… Non-muscle Invasive Bladder Cancer (NMIBC) Recruiting
NCT07131202 A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors Advanced Solid Tumors Recruiting
Phase 1
NCT07131189 A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors Locally Advanced/Metastatic Solid Tumors Active, Not Recruiting
Disease Areas
Bladder Cancer (1)
Get alerts when Suzhou Forlong Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free